Seven regulators, including IGF2BP2, METTL3, METTL16, ZNF217, ZC3H13, RBM15B, and PRRC2A, exhibited significant correlations between CNVs and gene expression levels in prostate tumors (Figure 3). This evidence concerns the gene ZC3H13 and prostate neoplasm.